Page last updated: 2024-10-29

amrinone and Mitral Stenosis

amrinone has been researched along with Mitral Stenosis in 1 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to investigate the haemodynamic effects of amrinone in patients with pulmonary hypertension and impaired right ventricular function."7.67The haemodynamic effects of amrinone in patients with mitral stenosis and pulmonary hypertension. ( Arnold, B; Hess, W; Veit, S, 1986)
"The aim of this study was to investigate the haemodynamic effects of amrinone in patients with pulmonary hypertension and impaired right ventricular function."3.67The haemodynamic effects of amrinone in patients with mitral stenosis and pulmonary hypertension. ( Arnold, B; Hess, W; Veit, S, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hess, W1
Arnold, B1
Veit, S1

Other Studies

1 other study available for amrinone and Mitral Stenosis

ArticleYear
The haemodynamic effects of amrinone in patients with mitral stenosis and pulmonary hypertension.
    European heart journal, 1986, Volume: 7, Issue:9

    Topics: Adult; Amrinone; Female; Heart Rate; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Age

1986